GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IVERIC bio Inc (FRA:O2T) » Definitions » YoY Rev. per Sh. Growth

IVERIC bio (FRA:O2T) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2023)


View and export this data going back to 2013. Start your Free Trial

What is IVERIC bio YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. IVERIC bio's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 was 0.00%.

IVERIC bio's Revenue per Share for the three months ended in Mar. 2023 was €0.00.

IVERIC bio YoY Rev. per Sh. Growth Historical Data

The historical data trend for IVERIC bio's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVERIC bio YoY Rev. per Sh. Growth Chart

IVERIC bio Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.00 - - - -

IVERIC bio Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IVERIC bio YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

IVERIC bio's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2022 )
=(Revenue per Share (A: Dec. 2022 )-Revenue per Share (A: Dec. 2021 ))/ | Revenue per Share (A: Dec. 2021 ) |
=(0-0)/ | 0 |
=N/A %

IVERIC bio's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2023 )
=(Revenue per Share (Q: Mar. 2023 )-Revenue per Share (Q: Mar. 2022 )) / | Revenue per Share (Q: Mar. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IVERIC bio YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of IVERIC bio's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

IVERIC bio (FRA:O2T) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IVERIC bio Inc (FRA:O2T) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
VCYT CLDX PRTA VCEL CELU ZNTL RVMD RCUS MDGL MNKD OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
8 Sylvan Way, Parsippany, New Jersey, USA, 07054
Website
https://www.ivericbio.com
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

IVERIC bio (FRA:O2T) Headlines

No Headlines